Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.750
+0.160 (3.49%)
At close: Dec 5, 2025, 4:00 PM EST
4.760
+0.010 (0.21%)
After-hours: Dec 5, 2025, 4:10 PM EST
Radiopharm Theranostics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Cash & Equivalents | 29.12 | 18.58 | 11.7 | 26.98 | 0.03 |
| Cash & Short-Term Investments | 29.12 | 18.58 | 11.7 | 26.98 | 0.03 |
| Cash Growth | 56.75% | 58.77% | -56.64% | 99486.97% | - |
| Accounts Receivable | - | - | 0.1 | 0.06 | - |
| Other Receivables | 10.4 | 0.99 | 4.36 | 0 | 0.01 |
| Receivables | 10.4 | 0.99 | 4.47 | 0.06 | 0.01 |
| Other Current Assets | 0.34 | 3.29 | 0.13 | 0.23 | - |
| Total Current Assets | 39.85 | 22.85 | 16.3 | 27.26 | 0.03 |
| Property, Plant & Equipment | 0.05 | 0.06 | 0.07 | 0 | - |
| Other Intangible Assets | 46.57 | 49.09 | 58.54 | 56.08 | - |
| Other Long-Term Assets | - | 0.04 | 0.04 | 0.04 | - |
| Accounts Payable | 6.35 | 6.43 | 2.96 | 1.19 | 0.06 |
| Accrued Expenses | 3.2 | 2.57 | 2.11 | 1.02 | 0.03 |
| Short-Term Debt | - | - | - | - | 0.06 |
| Current Unearned Revenue | 1.72 | - | - | - | - |
| Other Current Liabilities | 3.66 | 8.57 | 8.16 | 5.66 | - |
| Total Current Liabilities | 14.93 | 17.58 | 13.23 | 7.88 | 0.16 |
| Other Long-Term Liabilities | 28.68 | 27.11 | 16.14 | 12.54 | - |
| Common Stock | 176.56 | 100.68 | 97.23 | 86.76 | 0 |
| Retained Earnings | -145.73 | -111.34 | -65.35 | -30.91 | -0.49 |
| Comprehensive Income & Other | 13.97 | 38.78 | 12.51 | 7.11 | 0.36 |
| Total Common Equity | 44.79 | 28.12 | 44.38 | 62.96 | -0.12 |
| Minority Interest | -1.92 | -0.77 | 1.19 | - | - |
| Total Liabilities & Equity | 86.48 | 72.04 | 74.95 | 83.38 | 0.03 |
| Total Debt | - | - | - | - | 0.06 |
| Net Cash (Debt) | 29.12 | 18.58 | 11.7 | 26.98 | -0.03 |
| Net Cash Growth | 56.75% | 58.77% | -56.64% | - | - |
| Net Cash Per Share | 0.01 | 0.05 | 0.04 | 0.15 | - |
| Filing Date Shares Outstanding | 2,365 | 2,173 | 339.31 | 255.43 | 100 |
| Total Common Shares Outstanding | 2,365 | 460.37 | 339.31 | 255.43 | 100 |
| Working Capital | 24.92 | 5.27 | 3.07 | 19.39 | -0.12 |
| Book Value Per Share | 0.02 | 0.06 | 0.13 | 0.25 | -0.00 |
| Tangible Book Value | -1.78 | -20.96 | -14.16 | 6.89 | -0.12 |
| Tangible Book Value Per Share | -0.00 | -0.05 | -0.04 | 0.03 | -0.00 |
Source: S&P Capital IQ. Standard template.
Financial Sources.